Ketogenic Diet Shrinks Synaptic Vesicle Pools, Pointing to New Anti-Seizure Targets

The ketogenic diet has been used to treat epilepsy since the 1920s. In patients whose seizures do not respond to standard medications - a group accounting for roughly one-third of all epilepsy cases - the high-fat, near-zero-carbohydrate diet can reduce seizure frequency by approximately 50% when followed strictly. The therapeutic effect is real and well-documented. What has remained genuinely unknown is what is happening inside the brain to produce it.

A study from Washington University School of Medicine in St. Louis, published in Cell Reports, now provides a cellular-level explanation. Working with mice maintained on a diet of high-fat pellets, Ghazaleh Ashrafi, PhD, and co-senior authors Gabor Egervari and Vitaly Klyachko used genomic analysis and direct electrophysiological measurement to identify the specific changes in neuron behavior that the diet induces.

Starting with the Hippocampus

The hippocampus is where seizures commonly originate in temporal lobe epilepsy, the most prevalent form of the disease. Ashrafi's team focused their genetic analysis there. In mice on the ketogenic diet, they found hundreds of alterations in gene expression compared to mice on a standard diet. Many of these altered genes were connected to synaptic function - the molecular machinery that governs how neurons send signals to one another at junctions called synapses.

Synapses operate through vesicles: tiny membrane-enclosed packets within the neuron that store neurotransmitter molecules. When a neuron fires, vesicles fuse with the cell membrane and release their contents into the synaptic cleft, where they activate receptors on the neighboring cell. The number and release properties of those vesicles determine the strength of the signal.

Fewer Vesicles, Quieter Circuits

Using high-powered microscopy, the researchers measured vesicle counts directly in neurons from mice on the ketogenic diet and mice on a standard diet. Neurons from keto-diet mice had measurably fewer vesicles containing excitatory neurotransmitters - the signaling molecules that tell neighboring neurons to activate. Simultaneously, inhibitory signaling increased.

The combined effect was to dampen the strength of communication within brain circuits. Excitatory signals became weaker; inhibitory signals became stronger. A brain in that state is less likely to generate the uncontrolled, synchronized electrical activity that constitutes a seizure.

"By better understanding how the diet works, it provides new avenues to develop interventions that are not as strict as the diet itself but still control seizures," said Ashrafi.

From Mechanism to Potential Therapeutics

The key therapeutic implication is that the ketogenic diet's anti-seizure effects appear to operate through a specific, identifiable cellular pathway - the reduction of excitatory vesicle pools - rather than through some diffuse metabolic effect of ketosis. That specificity defines a target. Medications or other interventions that reduce excitatory vesicle count in hippocampal neurons without requiring extreme dietary restriction could, in principle, replicate the anti-seizure benefit without the compliance burden. Most patients find the standard ketogenic diet - in which 90% of calories must come from fat - extremely difficult to sustain, and even small deviations can eliminate its benefits.

"If we can mimic the molecular changes that are causing neurons to make fewer of these vesicles, we can mimic the anti-seizure effect without needing to profoundly change a patient's diet," Ashrafi said.

Important Caveats: Mouse Model Limitations

The study was conducted entirely in mice. Their neurons function similarly to human neurons, but the translation from mouse findings to human treatment is never guaranteed. Epilepsy is mechanistically diverse: what works for one seizure type may not work for another, and mouse models capture specific aspects of epilepsy biology without replicating its full clinical complexity. Whether the vesicle reduction observed in mice reflects what happens in the brains of human epilepsy patients on the ketogenic diet remains to be established through future research.

The study was supported by multiple funders including the McDonnell Center for Systems Neuroscience, NIH grants, and the Chan-Zuckerberg Initiative Early Acceleration Award.